UQ researchers are attempting to create a vaccine in just 150 days to prove how far their response capabilities to a viral pandemic have come since COVID-19.
16 April 2025
Koalas from a population north of the Brisbane River have evolved a unique genomic immunity to the killer retrovirus threatening their species.
13 March 2025
Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland’s molecular clamp technology against life-threatening respiratory viruses.
7 November 2024
The University of Queensland’s re-engineered clamp platform has produced a vaccine that is equally safe and virus-neutralising as an approved vaccine considered among the best in its class.
23 November 2023
Recruitment is underway for a pivotal proof-of-concept human trial of The University of Queensland’s second-generation molecular clamp vaccine.
20 March 2023
University of Queensland virologists are a step closer to understanding a mysterious AIDS-like virus that is impacting koala populations differently across state lines.
30 November 2022
The University of Queensland is set to take a second-generation molecular clamp vaccine to a proof-of-concept human trial.
25 November 2022
An AIDS-like virus plaguing Australia’s koala population is leaving them more vulnerable to chlamydia and other threatening health conditions, University of Queensland research has found.
25 May 2022
The University of Queensland’s Associate Professor Dan Watterson has been awarded a $1.25 million CSL Centenary Fellowship to research accelerated pandemic treatments.
28 October 2021
A deadly koala virus that can cause immune depletion and cancer, known as koala retrovirus, is being transferred to joeys from their mothers, according to University of Queensland scientists.
7 September 2021
University of Queensland scientists have published the clinical trial data confirming their molecular clamp-stabilised vaccine technology was safe and potentially effective.
20 April 2021
A call to arms has gone out to Queenslanders aged 56 and over to help advance The University of Queensland’s COVID-19 vaccine project.
27 August 2020
Pre-clinical testing of The University of Queensland’s COVID-19 vaccine has produced positive indications about its potential effectiveness and manufacturability.
26 August 2020
The next critical phase for UQ's COVID-19 vaccine is underway – with the research effort moving out of the lab and into human trials.
13 July 2020
A landmark partnership will help to accelerate the future development, manufacture and distribution of a University of Queensland COVID-19 vaccine.
5 June 2020
The University of Queensland’s COVID-19 vaccine has passed another important milestone, showing the ability to raise high levels of antibodies that can neutralise the virus in early pre-clinical testing.
29 April 2020
The University of Queensland’s potential COVID-19 vaccine is entering an important new phase of testing with the live coronavirus to determine how effectively it induces protection against coronavirus infection.
9 April 2020
A funding injection of up to $17 million for vital University of Queensland research could help cut the timeline for an effective vaccine for COVID-19 by six months.
22 March 2020
The University of Queensland has been asked to develop a vaccine for the recent coronavirus outbreak at unprecedented speed, using new technology.
24 January 2020
Discovery of a type of immunity that protects koalas’ DNA from viruses has importance for the survival of koalas and our fundamental understanding of evolution.
14 October 2019- 1 of 2
- next ›
